Psoriasis. What is Psoriasis? What causes psoriasis? Medical Topics Psoriasis

Similar documents
Psoriasis: Causes, Symptoms, And Treatment

What is Psoriasis? Common Areas Affected. Type Who Does it Affect Characteristics

Psoriasis. Causes of Psoriasis

Topical Calcipotriol Algorithm

TREATMENT OPTIONS FOR PSORIASIS. Sandra Hanlon Dermatology Senior Charge Nurse NHS Ayrshire and Arran 07/03/17

Phototherapy and Photochemotherapy Treatment (Ultraviolet A [PUVA] and B [UBV])

KEY MESSAGES. Psoriasis patients are more prone to cardiovascular diseases, stroke, lymphoma and non-melanoma skin cancers, and increased mortality.

It is estimated that about 26,000 new cases of

Difference Between Seborrheic Dermatitis and Psoriasis

Psoriasis. Andrei Metelitsa, MD, FRCPC, FAAD Clinical Associate Professor, Dermatology, U of C Co-Director, Institute for Skin Advancement

The role of the practice nurse in managing psoriasis in primary care

Psoriasis management. A/Prof Amanda Oakley Dermatologist, Waikato

PSORIASIS PSORIASIS. Anatomic sites FACTS ABOUT PROSIASIS PSORIASIS 11/16/2017 STIGMATA OF PSORIASIS

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE

SELF-TEST QUESTIONNAIRE PSORIASIS. Plaque a raised lesion where the diameter is greater than the thickness. Number 2

Psoriasis Case presentation 2 Ahmad is 50 years old male came to the on call dermatologist with a 3 day history of feeling generally unwell and

50 microgram/g Calcipotriol and 500 microgram/g betamethasone (as dipropionate).

Predicting the Response to Phototherapy for Psoriasis Patients

PSORIASIS BEST PRACTICE IN MANAGEMENT

An otherwise healthy 12-year-old

Psoriasis is a chronic, inflammatory, Prescribing in children

PDP SELF-TEST QUESTIONNAIRE PSORIASIS. Plaque a raised lesion where the diameter is greater than the thickness. Number 2

A Pilot Study. Name of investigational product:

Psoriasis. Overview. Epidemiology. Epidemiology 08/08/2015. Dr Nigel Burrows Consultant Dermatologist Addenbrooke s Hospital

COMMON SKIN CONDITIONS IN PRIMARY CARE. Ibrahim M. Zayneh, MD Dermatology Private Practice, Portsmouth, Ohio

Skin Problems. Issues for a Child. Skin Problems. Paediatric Palliative Care For Home Based Carers. Common in children with HIV

Psoriasis. Dermatology. History. Examination. Background. Objective. Discussion. Keywords: psoriasis; skin diseases. Philip Clarke

Common Skin Diseases. MdAhadAli Khan Department of Pharmacy SUB

Enstilar , Version 3 PUBLIC SUMMARY OF RISK MANAGEMENT PLAN

Psoriasis. Jessica Kaffenberger, M.D. Assistant Professor of Dermatology Division of Dermatology The Ohio State University Wexner Medical Center

Dermatology elective for yr. 5. Natta Rajatanavin, MD. Div. of dermatology Dep. Of Medicine, Ramathibodi Hospital Mahidol University 23 rd Feb 2015

NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE. Proposed Health Technology Appraisal

1 P a g e. Systemic Juvenile Idiopathic Arthritis (SJIA) (1.3) Patients 2 years of age and older with active systemic juvenile idiopathic arthritis.

Psoriasis in Jordan: a single center experience

LNE & Spa the magazine for skin care and spa professionals December 2017 $7.50

Constitutional eczema

Subject: Remicade (Page 1 of 5)

Time to Learn. 6 th March 2018 Dr. Shirin Chakera GPwSI Integrated Dermatology Service

A Patient s Guide to Psoriatic Arthritis

Etanercept: a new option in paediatric plaque psoriasis

Psoriasis the latest recommendations for management: where can primary care make a real difference?

Retrospective 10 years review of 100 patients with psoriasis in the Kingdom of Saudi Arabia (KSA)

Betnovate RD (ready diluted) 0.025% w/w Cream betamethasone (as valerate)

Psoriasis is an inflammatory condition of the skin that

Elements for a Public Summary

Diagnosis and Management of Common and Infective Skin Diseases in Children at primary care level

What you need to know about your child s PSORIASIS. Psoriasis

INFLAMMATORY BOWEL DISEASE AND SKIN HEALTH KARA N. SHAH, MD, PHD KENWOOD DERMATOLOGY MARCH 4, 2018

Vulval dermatoses. Dr Fiona Lewis, Consultant Dermatologist St John s Institute of Dermatology, London & Heatherwood & Wexham Park Hospital, Slough

Common Skin Diseases. Md Ahad Ali Khan Department of Pharmacy SUB

Psoriatic arthritis FACTSHEET

The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION. 13 May 2009

Recognizing common Dermatologic conditions. Case presentations. CAPA 2015 Annual Conference. Tanya Nino, MD St. Joseph Heritage Medical Group

A Guide to Understanding. Psoriasis. Treatment and Management Options LIVING WITH. Psoriasis.

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see:

Common Superficial Fungal Infections

Prescribing Information

WHAT CAUSES PSORIASIS TO FLARE UP WHAT CAUSES PSORIASIS TO PDF PSORIASIS PSORIATIC ARTHRITIS MEDLINEPLUS

IMPORTANT : PLEASE READ

Clinical Trial Report Synopsis

Follow this and additional works at: Part of the Skin and Connective Tissue Diseases Commons

Combination Nonbiologic Therapy in Psoriasis. Sushil Tahiliani, MBBS, MD

BRAINZ POLICY AND PROCEDURE ON COMMUNICABLE DISEASES

Circle Yes or No Y N. [If no, skip to question 7.] 2. Does the patient have a diagnosis of ulcerative colitis? Y N. [If no, skip to question 4.

Irbenida H 150mg/12,5mg film-coated tablets

10/25/2018. Autoimmunity and how to treat it. Disclosure. Why do we get autoimmunity? James Verbsky MD/PhD Pediatric Rheumatology/Immunology

Alocado TM. Effect of Alocado TM complex treatment on PASI scores on psoriasis patients. Final report Prepared for:

forniture parafarmaceutiche

PART III: CONSUMER INFORMATION

FACTSHEET ADULT SEBORRHOEIC DERMATITIS. What is seborrhoeic dermatitis? Who gets and why? What does it look like?

Pharmacy Management Drug Policy

ustekinumab (Stelara )

Psoriatic Arthritis- Secondary Care

2017 Blue Cross and Blue Shield of Louisiana

過敏病科中心. Allergy Centre. Eczema. Allergy Centre 過敏病科中心. Allergy Centre. For enquiries and appointments, please contact us at:

PRODUCT MONOGRAPH. FLOCTAFENINE Floctafenine Tablets 200 mg and 400 mg THERAPEUTIC CLASSIFICATION. Anti-inflammatory, Analgesic

Corporate Medical Policy

Cigna Drug and Biologic Coverage Policy

Risk Management Plan Etoricoxib film-coated tablets

Medication Guide Enbrel (en-brel) (etanercept)

Some skin conditions

Pharmacy Management Drug Policy

Olumiant (baricitinib) tablets

Questions to ask your Doctor

4. Behçet s - Treatment

What you need to know about PSORIASIS. Psoriasis

An Everyday Guide to Eczema

Psoriatic Arthritis- Second Line Treatments

Skin lesions & Abrasions

What is Enbrel? Key features

Etoricoxib STADA 30 mg, 60 mg, 90 mg and 120 mg film-coated tablets , Version V1.2 PUBLIC SUMMARY OF THE RISK MANAGEMENT PLAN

1. Background: Infliximab is administered parenterally; therefore, it is not covered under retail pharmacy benefits.

Treating dermatomyositis

A Patient s Guide to. Treatments for Psoriatic Arthritis

Thursday, 21 October :53 - Last Updated Thursday, 11 November :27

Psoriasis: A Therapeutic Update. Presenter: Christine Moussa, PGY-4 Program Director: Stephen Kessler, D.O. Alta Dermatology/LECOM

Medical Policy An independent licensee of the Blue Cross Blue Shield Association

Remicade (Infliximab)

Communicable Disease Guidelines

Transcription:

1 Psoriasis What is Psoriasis? Psoriasis is a long standing inflammatory non-contagious skin disease which waxes and wanes with triggering factors. There is a genetic predisposition in psoriasis. Internationally, psoriasis affect about 2-3% of the population. The median age of onset is about 28 years old. Women are slightly more prevalent to have psoriasis. The salmon colored scaly plaques tend to occur on the elbows, knees, scalp, glans penis, buttock and lower back areas. They can also cause bone changes often termed psoriatic arthritis and nail changes. What causes psoriasis? Psoriasis is a complex skin disease affected by multiple factors like genetic, environmental and immune-mediated changes. The immune system over-reacts resulting in increased production of inflammatory markers like TNF-alpha and TH1 cytokines which trigger off inflammation cascade. This will cause increase proliferation of keratinocytes skin cells resulting in thickening and scaly skin. The inflammatory markers also result in the growth of skin blood vessels resulting in the change in color to salmon pink-red.

2 Psoriasis may also be triggered by other factors below: 1. Genetic: about 50% of affected individuals have an affected family member. 2. Koebner phenomenon: after the skin is scratched or undergone mechanical/chemical injury, psoriasis rash will occur around that area. 3. Stress: will also induce psoriasis rash 4. Environmental factors: changes in temperature and humidity may trigger psoriasis. However, sunlight is beneficial for psoriasis. 5. Infections: Fungal infection with Malassezia may trigger sebopsoriasis. Candida infection may trigger flexural psoriasis. Streptococcal upper respiratory tract infection may trigger guttate form of psoriasis. 6. Alcohol and smoking: have also been associated with increase flares of psoriasis. 7. Hormonal changes: Pregnancy and post puberty are times when psoriasis may occur hence there may be some relationship between them. 8. Medications: Beta-blockers (heart disease and hypertension medication), Lithium (psychiatric medication), sudden stopping of steroids, anti-malaria drug like hydroxychloroquinine and Non-Steroidal Anti-Inflammatory Drugs (NSAIDS) may trigger psoriasis. 9. Metabolic syndrome: Patients who are obese, insulin resistance, hypertension and hyperlipidemia have metabolic syndrome which has been associated with psoriasis.

3 Types of psoriasis Depending on the site of presentation and clinical features there are several forms of psoriasis as described below: 1. Erythrodermic psoriasis: this is severe psoriasis which involves the whole body.

4 2. Flexural psoriasis: well defined skin patches on skin folds like armpit areas, groin area, infra-mammary areas, cubital fossa of elbows and back of knee. 3. Guttate Psoriasis: widespread multiple small patches over the body 4. Intra-oral psoriasis: there will be blistering and ulcers in the mouth. 5. Koebnerised Psoriasis: Psoriasis that occur over healing wounds/scars. 6. Nail Psoriasis: characterized by nail changes like yellowing, ridging, pitting and onycholysis.

5 7. Plaque Psoriasis: large flat plaques mainly over elbows, knees and lower back.

6 8. Palmoplantar psoriasis: skin lesions mainly occur on palms and soles. 9. Pustular psoriasis: Pustules (lesions filled with pus) that can be found throughout the body or just involving the palms and soles.

7 10. Psoriatic arthritis: arthritis joint disease caused by psoriasis. 11. Scalp psoriasis: psoriasis that forms scaly plaques on the scalp.

8 12. Sebopsoriasis: resembling seborrhoeic dermatitis the lesions are localized at the scalp, face, ears and chest areas. Clinical features of Psoriasis Psoriasis is characterized by pink/red scaly patches (plaques) with well-defined edges symmetrically on the body. The scaly patches are often described as silvery-white. In pustular psoriasis the lesions are all pustules (bumps filled with pus). Common sites where these lesions occur are the elbows, knees, buttocks, lower back, scalp and glans penis area.

9 The skin lesions are often itchy and disfiguring if involves the whole body. They often cause psychological stress to patients as it is a chronic disease with no specific cure. Psoriasis can also affect the mouth cavity causing white lesions or ulceration. Psoriasis also can cause nail changes like pitting, ridging, onycholysis and yellowing of nail. It can also affect the bone causing arthritis associated with joint pain and swelling. In some patients, psoriasis may also affect the eyes causing blepharitis (inflammation of eyelid), conjunctivitis, ectropion (lower eyelid turns outwards), dry eyes and keratitis (cornea infection). Diagnosis of psoriasis Diagnosis is made by its typical clinical presentation. To differentiate psoriatic cause of arthritis from gout and rheumatoid arthritis blood tests to test for rheumatoid factor and uric acid can be done. Other than that investigations are usually not necessary for diagnostic purposes. Treatment of psoriasis To date, there is no definitive cure for psoriasis. Treatment modalities are to control the flares and symptoms. Reducing predisposing factors mentioned earlier may reduce frequency of flares. Therapy is aimed at reducing the rate of skin cell production. Moisturizers act as adjunct to improve the skin barrier. The different treatments available are:

10 1. Coal Tar It is an inexpensive ingredient often found in lotion, creams, shampoo and foam that can be used on all parts of body. Sometimes it is mixed with corticosteroids. It acts by reducing the itch, anti-bacteria and inhibiting cell proliferation. The only disadvantage is its smell, skin irritation and it stains clothes. 2. Topical corticosteroids Topical steroids have anti-inflammatory effects that not only reduce inflammation it also reduces formation of plaques. However, if it is stopped abruptly it can cause a rebound flare of psoriasis. Long term usage may also result in skin atrophy (thinning).

11 3. Opthalmic Corticosteroids Eye drops containing steroid are used to treat psoriasis eye conditions like corneal, conjunctiva and anterior chamber inflammation. It reduces the inflammation process, reduces the migration of white blood cells and controls the formation of new vessels. Artificial tears may also be helpful to treat dry eye conditions in psoriasis. 4. Anthralin Anthralin is a topical keratolytic agent which helps to remove skin scaling, smooth the skin and reduces cell proliferation. The side effects include staining of skin and skin irritation.

12 5. Vitamin D Analogues These are topical vitamin D synthetic analogues, calcitriol, that help to regulate skin cell production and development and also act as immunosupressants. Examples are Dovonex, sorilux and daivobet (combination of calcitriol with steroids). They are slightly more costly. Side effects include mild skin irritation and sometimes mild transient elevation of calcium levels. 6. Immunomodulators These are topical creams like tacrolimus and pimecrolimus which reduce inflammatory process. Most common side effects may be localized burning and itchy sensation. It is not recommended in pregnant and lactating women. There is a black box warning of cutaneous lymphoma done in animal studies.

13 7. Topical retinoids Topical retinoids like Tazorotene modulates the proliferation of skin cell, reduces inflammatory process and is an immunomodulators. It can cause skin irritation and is not recommended in pregnant women. 8. Phototherapy Phototherapy with PUVA and NBUVB may be recommended for patients with more extensive psoriasis patients involving >10-15% of body surface area. PUVA is used less frequently as it may increase skin cancer after prolonged and multiple phototherapy sessions.

14 9. Oral immunosupressants -Methotrexate: useful in patients with guttate psoriasis, psoriatic arthritis and patients who do not respond to topical creams and phototherapy. It inhibits cell growth and proliferation. Doses can range from 2.5-30 mg per week. It is contraindicated in patients who are pregnant, having active liver disease, active infections and alcoholism. Side effects include nausea, bone marrow suppression, liver toxicity, mouth ulcers, temporarily affect fertility and causes fetal deformity in pregnant women. Full blood count, renal function test and liver function test will be done regularly for monitoring. Sometimes, liver biopsy may also be necessary after 3.5-4 gm of medications or in those with increased risk of liver cancer.

15 -Cyclosporin is very effective in all kinds of psoriasis but it is more costly. It cannot be used beyond one year as it causes kidney damage. It is contraindicated in patients with active infections and cancers. It modulates the T cell function and in turn reduces the inflammation cascade. The dose is 2-5 mg per day. Side effects include raising blood pressure, kidney damage, high cholesterol, and high potassium level, induce gout, reduces magnesium level, liver enzymes derangement, abdomen pain, nausea and increased risk of cancers e.g. skin and lymphoproliferative cancers. Frequent blood test to test for lipids, uric acid, full blood count, liver function test and kidney function tests are required for monitoring. Blood pressure should also be monitored.

16 -Other drugs like azathioprine, mycophenolic mofetil, hydroxyurea and sulfasalazine can also be used depending on the patient s condition. All these drugs have different side effects so close monitoring by dermatologists is necessary. 10. Biologics Biologics are Biological Therapy agents are specially designed to block specific molecular steps in the formation of psoriasis lesions. It is useful for patients with extensive psoriasis involving > 10% of body surface area for at least 6 months, unresponsive to topical creams and those who cannot tolerate the side effects of phototherapy and immunosupressants. The available biologics include Alefacept, Efalizumab, Etanercept, Infliximab and Adalimumab. They are usually given in injectable forms and dosage is dependent on each drug. Each has its own side effects hence it can only be given and monitored by certified dermatologists.